The Native Antigen Company
The Native Antigen Company is one of the world’s leading suppliers of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases. The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke product development and custom manufacturing using its proprietary mammalian cell expression system.
Content by The Native Antigen Company
|2 min read
The Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies
These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses
|2 min read
The Native Antigen Company Introduces Custom Service for Influenza Antigens
Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B virusesPage 1 of 1
